rs10112748

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001382391.1(CSPP1):​c.3165T>C​(p.Asp1055Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00353 in 1,594,980 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0022 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0037 ( 7 hom. )

Consequence

CSPP1
NM_001382391.1 synonymous

Scores

3

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.247

Publications

6 publications found
Variant links:
Genes affected
CSPP1 (HGNC:26193): (centrosome and spindle pole associated protein 1) This gene encodes a centrosome and spindle pole associated protein. The encoded protein plays a role in cell-cycle progression and spindle organization, regulates cytokinesis, interacts with Nephrocystin 8 and is required for cilia formation. Mutations in this gene result in primary cilia abnormalities and classical Joubert syndrome. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Apr 2014]
ARFGEF1 (HGNC:15772): (ADP ribosylation factor guanine nucleotide exchange factor 1) ADP-ribosylation factors (ARFs) play an important role in intracellular vesicular trafficking. The protein encoded by this gene is involved in the activation of ARFs by accelerating replacement of bound GDP with GTP. It contains a Sec7 domain, which may be responsible for guanine-nucleotide exchange activity and also brefeldin A inhibition. [provided by RefSeq, Aug 2011]
ARFGEF1 Gene-Disease associations (from GenCC):
  • developmental delay, impaired speech, and behavioral abnormalities, with or without seizures
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Illumina, Labcorp Genetics (formerly Invitae), G2P
  • schizophrenia
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001382391.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BP6
Variant 8-67179871-T-C is Benign according to our data. Variant chr8-67179871-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 434844.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.247 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00217 (331/152258) while in subpopulation NFE AF = 0.00413 (281/68014). AF 95% confidence interval is 0.00373. There are 1 homozygotes in GnomAd4. There are 150 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 7 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001382391.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CSPP1
NM_001382391.1
MANE Select
c.3165T>Cp.Asp1055Asp
synonymous
Exon 28 of 31NP_001369320.1A0A7I2V5W3
CSPP1
NM_001364869.1
c.3231T>Cp.Asp1077Asp
synonymous
Exon 27 of 30NP_001351798.1A0A7I2PHE7
CSPP1
NM_024790.7
c.3150T>Cp.Asp1050Asp
synonymous
Exon 26 of 29NP_079066.5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CSPP1
ENST00000678616.1
MANE Select
c.3165T>Cp.Asp1055Asp
synonymous
Exon 28 of 31ENSP00000504733.1A0A7I2V5W3
CSPP1
ENST00000262210.11
TSL:1
c.3231T>Cp.Asp1077Asp
synonymous
Exon 27 of 30ENSP00000262210.6A0A7I2PHE7
CSPP1
ENST00000519668.1
TSL:1
c.2115T>Cp.Asp705Asp
synonymous
Exon 23 of 26ENSP00000430092.1Q1MSJ5-2

Frequencies

GnomAD3 genomes
AF:
0.00218
AC:
331
AN:
152140
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000845
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000327
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000189
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00413
Gnomad OTH
AF:
0.00192
GnomAD2 exomes
AF:
0.00187
AC:
462
AN:
247682
AF XY:
0.00187
show subpopulations
Gnomad AFR exome
AF:
0.000970
Gnomad AMR exome
AF:
0.000205
Gnomad ASJ exome
AF:
0.000498
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000422
Gnomad NFE exome
AF:
0.00369
Gnomad OTH exome
AF:
0.00166
GnomAD4 exome
AF:
0.00368
AC:
5303
AN:
1442722
Hom.:
7
Cov.:
26
AF XY:
0.00346
AC XY:
2490
AN XY:
718928
show subpopulations
African (AFR)
AF:
0.000634
AC:
21
AN:
33100
American (AMR)
AF:
0.000180
AC:
8
AN:
44488
Ashkenazi Jewish (ASJ)
AF:
0.000424
AC:
11
AN:
25962
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39548
South Asian (SAS)
AF:
0.0000117
AC:
1
AN:
85304
European-Finnish (FIN)
AF:
0.000642
AC:
34
AN:
52974
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5724
European-Non Finnish (NFE)
AF:
0.00465
AC:
5100
AN:
1095852
Other (OTH)
AF:
0.00214
AC:
128
AN:
59770
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.452
Heterozygous variant carriers
0
207
414
620
827
1034
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
210
420
630
840
1050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00217
AC:
331
AN:
152258
Hom.:
1
Cov.:
32
AF XY:
0.00202
AC XY:
150
AN XY:
74438
show subpopulations
African (AFR)
AF:
0.000842
AC:
35
AN:
41558
American (AMR)
AF:
0.000327
AC:
5
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
4
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.000189
AC:
2
AN:
10596
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00413
AC:
281
AN:
68014
Other (OTH)
AF:
0.00190
AC:
4
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
17
34
50
67
84
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00347
Hom.:
5
Bravo
AF:
0.00223
EpiCase
AF:
0.00354
EpiControl
AF:
0.00314

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not provided (4)
-
-
1
Joubert syndrome 21 (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.68
CADD
Benign
8.6
DANN
Benign
0.86
PhyloP100
0.25
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.14
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs10112748;
hg19: chr8-68092106;
COSMIC: COSV99138122;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.